Ágnes Balogh
University of Debrecen(HU)Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Melanoma and MAPK Pathways, Hungarian Social, Economic and Educational Studies
Most-Cited Works
- → Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma(2019)3,640 cited
- → Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial(2012)1,080 cited
- → Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer(2017)138 cited
- → A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.(1996)98 cited
- → Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).(2019)82 cited
- → Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs(2006)81 cited